Anaerobe 18 , 260262 (2012)
On July 23-24, 2026 , the FDA's Pharmacy Compounding Advisory Committee (PCAC) will convene at the FDA White Oak Campus (10903 New Hampshire Avenue, Silver Spring, MD 20993) to evaluate whether several peptides should be added to the Section 503A bulk drug substances list
Direction of Future Research A multicenter randomized clinical trial is current in progress in Spain primary health-care setting called Project OB12 (24)
Mechanisms underlying neuroprotection include enhanced cerebral angiogenesis supporting tissue oxygenation, anti-inflammatory effects reducing secondary injury, antioxidant activity limiting free radical damage, and modulation of neurotransmitter systems including the dopamine/glutamate/NO system
When Wnt signaling declines with age, regeneration slows
Boost fat metabolism